Hyaluronic acid-modified cationic nanoparticles overcome enzyme CYP1B1-mediated breast cancer multidrug resistance

被引：18
|
作者：
Zhang, Jun [1 ]
Song, Jia [1 ]
Liang, Xiao [1 ]
Yin, Yunzhi [1 ]
Zuo, Tiantian [1 ]
Chen, Daijie [1 ]
Shen, Qi [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Pharm, 800 Dongchuan Rd, Shanghai 200240, Peoples R China
来源：
NANOMEDICINE | 2019年 / 14卷 / 04期
关键词：
alpha-napthtoflavone; breast cancer; CD44; CYP1B1; DTX; hyaluronic acid; lysosome escape; multidrug resistance; nanoparticles; polyethyleneimine; MESOPOROUS SILICA; ANTICANCER DRUGS; DELIVERY; DOCETAXEL; MICELLES; CYP1B1; CYTOCHROME-P450; PACLITAXEL; CELLS; FORMULATIONS;
D O I：
10.2217/nnm-2018-0244
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Aim: Enzyme CYP1B1 (CYP1B1) is usually overexpressed in multidrug resistance (MDR) breast cancer cells, which could metabolically inactivate docetaxel (DTX). Materials & methods: The cationic core-shell nanoparticles (hyaluronic acid/polyethyleneimine nanoparticles[HA/PEI NPs]) modified with hyaluronic acid (HA) were developed and coloaded with DTX and alpha-napthtoflavone (ANF, a CYP1B1 inhibitor) to overcome MDR in breast cancer induced by CYP1B1. Physicochemical characterization, MDR reversing effect in vitro and pharmacokinetics in vivo of HA/PEI NPs were evaluated. Results: The HA/PEI NPs exhibited spherical morphology with size of (193.6 +/- 3.1) nm. The HA/PEI NPs could reverse MDR effectively by downregulating the expression of CYP1B1. The HA/PEI NPs improved the bioavailability of DTX. Conclusion:The HA/PEI NPs might be a promising strategy to overcome CYP1B1-mediated breast cancer MDR. [GRAPHICS]
引用
收藏
页码：447 / 464
页数：18
相关论文
共 50 条
  • [31] Redefine the role of D-α-Tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein, multidrug resistance protein 1, and breast cancer resistance protein mediated cancer multidrug resistance
    Chen, Jing-Yi
    Sung, Chieh-Ju
    Chen, Ssu-Chi
    Hsiang, Yi-Ping
    Hsu, Yung-Chia
    Teng, Yu-Ning
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 190
  • [32] Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles
    Wu, Yang
    Zhang, Yu
    Zhang, Wei
    Sun, Chunlong
    Wu, Jianzhong
    Tang, Jinhai
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2016, 138 : 60 - 69
  • [33] Development of hyaluronic acid-anchored polycaprolactone nanoparticles for efficient delivery of PLK1 siRNA to breast cancer
    Jain, Dolly
    Yadav, Awesh K.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2023, 13 (06) : 1730 - 1744
  • [34] B7-H3-mediated deubiquitination stabilizing CYP1B1 expression promotes chemotherapy resistance in colorectal cancer
    Liu, Huan
    Li, Guifang
    Shen, Chenjie
    Qi, Xiaowei
    Liu, Yankui
    Hua, Dong
    Mao, Yong
    Zhang, Ting
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2025, 1871 (05):
  • [35] FRAX486, a PAK inhibitor, overcomes ABCB1-mediated multidrug resistance in breast cancer cells
    Zhang, Meng
    Zeng, Xiaoqi
    She, Meiling
    Dong, Xingduo
    Chen, Jun
    Xiong, Qingquan
    Qiu, Guobin
    Yang, Shuyi
    Li, Xiangqi
    Ren, Guanghui
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2024, 57
  • [36] Targeting tumor highly-expressed LAT1 transporter with amino acid-modified nanoparticles: Toward a novel active targeting strategy in breast cancer therapy
    Li, Lin
    Di, Xingsheng
    Wu, Mingrui
    Sun, Zhisu
    Zhong, Lu
    Wang, Yongjun
    Fu, Qiang
    Kan, Qiming
    Sun, Jin
    He, Zhonggui
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (03) : 987 - 998
  • [37] Development of vitamin D-resistance in breast cancer cells through SLUG-mediated coordinate repression of CYP2R1, CYP27B1 and VDR gene promoters
    Mittal, Mukul Kumar
    Misra, Smita
    Chaudhuri, Gautam
    FASEB JOURNAL, 2012, 26
  • [38] Long-term cadmium exposure induces epithelial-mesenchymal transition in breast cancer cells by activating CYP1B1-mediated glutamine metabolic reprogramming in BT474 cells and MMTV-Erbb2 mice
    Li, Jingdian
    Gao, Peng
    Qin, Mingke
    Wang, Junhua
    Luo, Yan
    Deng, Ping
    Hao, Rongrong
    Zhang, Lei
    He, Mindi
    Chen, Chunhai
    Lu, Yonghui
    Ma, Qinlong
    Li, Min
    Tan, Miduo
    Wang, Liting
    Yue, Yang
    Wang, Hui
    Tian, Li
    Xie, Jia
    Chen, Mengyan
    Yu, Zhengping
    Zhou, Zhou
    Pi, Huifeng
    SCIENCE OF THE TOTAL ENVIRONMENT, 2024, 918
  • [39] Activity-dependent and graded BACE1 expression in the olfactory epithelium is mediated by the retinoic acid metabolizing enzyme CYP26B1
    Hande Login
    Rafal Butowt
    Staffan Bohm
    Brain Structure and Function, 2015, 220 : 2143 - 2157
  • [40] Activity-dependent and graded BACE1 expression in the olfactory epithelium is mediated by the retinoic acid metabolizing enzyme CYP26B1
    Login, Hande
    Butowt, Rafal
    Bohm, Staffan
    BRAIN STRUCTURE & FUNCTION, 2015, 220 (04): : 2143 - 2157
12345